FTM
KYMR icon

First Turn Management’s Kymera Therapeutics KYMR Stock Holding History

First Turn Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Sell
102,533
-152,139
-60% -$13.1M 1.26% 29
2026
Q1 		$21.2M Buy
254,672
+48,227
+23% +$3.82M 2.37% 18
2025
Q4 		$16.1M Sell
206,445
-71,281
-26% -$4.81M 1.84% 26
2025
Q3 		$15.7M Buy
+277,726
New +$12.5M 2.36% 21

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

First Turn Management's KYMR Position: Q2 2026 in Review

First Turn Management reduced its Kymera Therapeutics (KYMR) stake by 60% in Q2 2026, selling an estimated $13.1M and leaving 102,533 shares worth $11.8M. The position accounts for 1.26% of the portfolio, ranked #29.

First Turn Management first reported a position in KYMR in Q3 2025 and has held it in 4 quarters since. The position peaked at $21.2M in Q1 2026. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • First Turn Management held 102,533 shares of Kymera Therapeutics worth $11.8M as of Q2 2026.
  • First Turn Management sold 152,139 Kymera Therapeutics shares in Q2 2026, an estimated $13.1M.
  • Kymera Therapeutics made up 1.26% of First Turn Management's portfolio in Q2 2026, its #29 holding.
  • First Turn Management first reported a position in Kymera Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • First Turn Management's Kymera Therapeutics position peaked at $21.2M in Q1 2026.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.